$21,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing Act PREEMPT Act (H.R. 9061) to promote the appropriate use of advanced preeclampsia biomarker testing as part of the Medicaid program. Seeking Senate companion legislation."
You can find more data on corporate lobbying on Quiver Quantitative.
TMO Congressional Stock Trading
Members of Congress have traded $TMO stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $TMO stock by members of Congress over the last 6 months:
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
TMO Insider Trading Activity
TMO insiders have traded $TMO stock on the open market 36 times in the past 6 months. Of those trades, 0 have been purchases and 36 have been sales.
Here’s a breakdown of recent trading of $TMO stock by insiders over the last 6 months:
- MARC N CASPER (Chairman & CEO) has made 0 purchases and 33 sales selling 14,000 shares for an estimated $7,136,750.
- MICHAEL D SHAFER (Executive Vice President) sold 1,607 shares for an estimated $802,535
- GIANLUCA PETTITI (President & COO) has made 0 purchases and 2 sales selling 800 shares for an estimated $401,544.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
TMO Hedge Fund Activity
We have seen 993 institutional investors add shares of TMO stock to their portfolio, and 1,199 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- J. STERN & CO. LLP removed 31,454,483 shares (-99.8%) from their portfolio in Q1 2026, for an estimated $15,176,001,685
- CAPITAL WORLD INVESTORS removed 4,357,498 shares (-39.6%) from their portfolio in Q1 2026, for an estimated $2,102,383,847
- CAPITAL INTERNATIONAL INVESTORS added 2,968,583 shares (+322.6%) to their portfolio in Q1 2026, for an estimated $1,432,267,082
- AUTO-OWNERS INSURANCE CO removed 2,423,706 shares (-99.8%) from their portfolio in Q1 2026, for an estimated $1,169,377,552
- ROCKEFELLER CAPITAL MANAGEMENT L.P. removed 2,058,664 shares (-82.8%) from their portfolio in Q1 2026, for an estimated $993,253,913
- WELLINGTON MANAGEMENT GROUP LLP removed 1,989,989 shares (-57.4%) from their portfolio in Q1 2026, for an estimated $960,119,942
- CAPITAL RESEARCH GLOBAL INVESTORS added 1,499,720 shares (+51.5%) to their portfolio in Q1 2026, for an estimated $723,577,407
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
TMO Analyst Ratings
Wall Street analysts have issued reports on $TMO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/30/2026
To track analyst ratings and price targets for TMO, check out Quiver Quantitative's $TMO forecast page.
TMO Price Targets
Multiple analysts have issued price targets for $TMO recently. We have seen 11 analysts offer price targets for $TMO in the last 6 months, with a median target of $600.0.
Here are some recent targets:
- Vijay Kumar from Evercore ISI Group set a target price of $570.0 on 07/06/2026
- Eve Burstein from Bernstein set a target price of $520.0 on 06/26/2026
- David Westenberg from Piper Sandler set a target price of $510.0 on 06/11/2026
- Sidharth Sahoo from HSBC set a target price of $540.0 on 06/03/2026
- Mike Polark from Wolfe Research set a target price of $535.0 on 06/02/2026
- Brandon Couillard from Wells Fargo set a target price of $615.0 on 05/08/2026
- Catherine Schulte from Baird set a target price of $639.0 on 04/24/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
Read full article here »
View the Zacks #1 Rank List
Lobbying Update: $21,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed
$21,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing Act PREEMPT Act (H.R. 9061) to promote the appropriate use of advanced preeclampsia biomarker testing as part of the Medicaid program. Seeking Senate companion legislation."
You can find more data on corporate lobbying on Quiver Quantitative.
TMO Congressional Stock Trading
Members of Congress have traded $TMO stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $TMO stock by members of Congress over the last 6 months:
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
TMO Insider Trading Activity
TMO insiders have traded $TMO stock on the open market 36 times in the past 6 months. Of those trades, 0 have been purchases and 36 have been sales.
Here’s a breakdown of recent trading of $TMO stock by insiders over the last 6 months:
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
TMO Hedge Fund Activity
We have seen 993 institutional investors add shares of TMO stock to their portfolio, and 1,199 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
TMO Analyst Ratings
Wall Street analysts have issued reports on $TMO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
To track analyst ratings and price targets for TMO, check out Quiver Quantitative's $TMO forecast page.
TMO Price Targets
Multiple analysts have issued price targets for $TMO recently. We have seen 11 analysts offer price targets for $TMO in the last 6 months, with a median target of $600.0.
Here are some recent targets:
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
Read full article here »